• 1. Ultrafast dynamics of the ESIPT photoswitch N-(3-pyridinyl)-2-pyridinecarboxamide
  Hendrik B?hnke,Julia Bahrenburg,Xiaonan Ma,Katharina R?ttger,Christian N?ther,Micha? F. Rode,Andrzej L. Sobolewski,Friedrich Temps Phys. Chem. Chem. Phys. 2018 20 2646
• 2. Trimorphism of N-(3-pyridyl)-benzamide
  Christian N?ther,Inke Jess,Julia Bahrenburg,Dennis Bank,Friedrich Temps CrystEngComm 2014 16 5633
• 3. Photophysical properties of betaxanthins: miraxanthin?V – insight into the excited-state deactivation mechanism from experiment and computations
  Stanis?aw Niziński,Monika Wendel,Micha? F. Rode,Dorota Pruka?a,Marek Sikorski,S?awomir Wybraniec,Gotard Burdziński RSC Adv. 2017 7 6411

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxamides
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Pyridines and derivatives Pyridinecarboxylic acids and derivatives Pyridinecarboxamides

Professional Introduction to N-(pyridin-3-yl)pyridine-2-carboxamide (CAS No. 184870-10-8)

N-(pyridin-3-yl)pyridine-2-carboxamide, identified by its CAS number 184870-10-8, is a significant compound in the realm of chemical and pharmaceutical research. This heterocyclic amide derivative has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The compound's molecular framework, featuring two pyridine rings connected through an amide linkage, makes it a versatile scaffold for designing novel bioactive molecules.

The< strong>pyridin-3-yl moiety, a key feature of this compound, contributes to its ability to interact with biological targets in a specific manner. Pyridine derivatives are well-known for their role in pharmaceuticals, often serving as pharmacophores in drugs targeting neurological disorders, infectious diseases, and cancer. The presence of the amide group at the 2-position of the second pyridine ring enhances the compound's solubility and reactivity, making it a valuable intermediate in synthetic chemistry.

In recent years, there has been a surge in research focused on developing small-molecule inhibitors for various therapeutic targets. N-(pyridin-3-yl)pyridine-2-carboxamide has been explored as a potential lead compound in this context. Its structural motif is reminiscent of known active ingredients that have shown promise in preclinical studies. For instance, related pyridine-based compounds have been investigated for their efficacy in modulating kinases and other enzymes involved in signal transduction pathways.

The< strong>pyridine-3-yl group is particularly interesting because it can engage in hydrogen bonding and π-stacking interactions with biological macromolecules. These interactions are crucial for the binding affinity of drug candidates. Computational studies have suggested that N-(pyridin-3-yl)pyridine-2-carboxamide can effectively dock into the active sites of target proteins, potentially leading to the development of potent inhibitors.

Moreover, the amide functionality provides a site for further chemical modification, allowing researchers to fine-tune the properties of the compound. This flexibility has enabled the synthesis of analogues with enhanced pharmacokinetic profiles or improved binding affinity. For example, modifications at the 3-position of the first pyridine ring have been explored to optimize solubility and metabolic stability.

The pharmaceutical industry has shown particular interest in N-(pyridin-3-yl)pyridine-2-carboxamide due to its potential as a building block for drug discovery programs. Its structural features align well with current trends in medicinal chemistry, where multitarget engagement and structure-based drug design are gaining prominence. Several academic groups have reported preliminary findings on its interactions with enzymes and receptors relevant to human health.

In conclusion, N-(pyridin-3-yl)pyridine-2-carboxamide(CAS No. 184870-10-8) represents a promising candidate for further exploration in pharmaceutical research. Its unique structural attributes and potential biological activities make it a valuable asset in the quest for novel therapeutic agents. As research continues to uncover new applications for this compound, it is likely to play an increasingly important role in the development of next-generation drugs.

• 10354-53-7(Picolinic Anilide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)